Oral isotretinoin safe for treating acne in patients on dialysis: Study
London, UK: A recent study has found that low-dose isotretinoin (10-20mg) can be used safely and successfully for the treatment of severe acne in patients on renal dialysis. This significantly improves the patients' quality of life. The findings of the study are published in the journal Clinical and Experimental Dermatology.
Authors of the review article A. Gan and A. Therianou from St Mary's Hospital, Imperial College NHS Healthcare Trust, London, UK, further suggests that more studies would be more beneficial for further establishing isotretinoin's safe use in patients on renal dialysis as there is a scarcity of current literature on this topic.
The objective of the study was to systematically review the literature regarding the safety and efficacy of isotretinoin for the treatment of acne in patients on renal dialysis.
For this purpose, the researchers systematically searched the online databases in March 2021. The studies reporting the use of isotretinoin for the treatment of acne in patients with renal impairment or on renal dialysis, and having relevant implications to this topic were included.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.